Diabete Type 2 Clinical Trial
— VALIDOfficial title:
Living Together With Chronic Disease: Informal Support for Diabetes Management in Vietnam
Verified date | October 2022 |
Source | Thai Binh University of Medicine and Pharmacy |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Insufficient self-management is a significant barrier for people with type 2 diabetes (T2D) to achieve glycemic control and reduce the risk of acute and long-term diabetes complications which negatively affect the quality of life and increase the risk of diabetes-related death. This pre-post study aimed to evaluate the impact of a peer-based club intervention to improve self-management among people living with T2D in two rural communities in Vietnam.
Status | Active, not recruiting |
Enrollment | 229 |
Est. completion date | May 31, 2023 |
Est. primary completion date | January 11, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Individuals diagnosed with or treated for T2D over 18 years old - Residing in two selected communes - Without acute and/or severe illness - Able to answer the questionnaire completely - Agreed to participate voluntarily - Participated in both pre - post-study and the intervention program. Exclusion Criteria: - Refusal to continue participating in study - Migration - Illness or hospitalization |
Country | Name | City | State |
---|---|---|---|
Vietnam | Thai Binh University of Medicine and Pharmacy | Thai Binh |
Lead Sponsor | Collaborator |
---|---|
Thai Binh University of Medicine and Pharmacy | University of Copenhagen, University of Southern Denmark |
Vietnam,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in glycated haemoglobin from baseline to 12 months post intervention | HbA1c goal for adults is 7 % or less | Baseline and 12 months post intervention | |
Secondary | Change in medication adherence -Morisky Medication Adherence Scale-8 (MMAS-8) from baseline | The total score ranged from 0 to 8 and was classified into three degrees of Medication adherence, including low (<6 points), medium (6 - <8 points), and high (8 points) | Start intervention and 12 months post intervention | |
Secondary | Change in body mass index - BMI from baseline | Body mass index (BMI) was calculated using the Asia-Pacific classification based on the formula of (weight (kg)/ [height (m)2 | Baseline and 12 months post intervention | |
Secondary | Change in mental health Self Reporting Questionnaire 20-Item (SRQ-20) from baseline | The clinical reference index of SRQ-20 is 7, where a score exceeding 7 is considered to reflect emotional pain. | Baseline and 12 months post intervention | |
Secondary | Change in systolic blood pressure from baseline | The systolic blood pressure (BP) reading were obtained with the left arm at the heart level using an automatic digital blood pressure monitor (Omron, Japan) | Baseline and 12 months post intervention | |
Secondary | Change in diastolic blood pressure from baseline | The diastolic blood pressure (BP) reading were obtained with the left arm at the heart level using an automatic digital blood pressure monitor (Omron, Japan) | Baseline and 12 months post intervention | |
Secondary | Change in quality of life measured by Short Form-36 (SF36) from baseline | The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. To score the SF-36, scales are standardized with a scoring algorithm or by the SF-36v2 scoring software to obtain a score ranging from 0 to 100. Higher scores indicate better health status.A mean score of 50 has been articulated as a normative value. | Baseline and 12 months post intervention | |
Secondary | change in awareness of hypo-/hyperglycemia from baseline | Ad hoc developed questions | Baseline and 12 months post intervention | |
Secondary | Change in self-management of diabetes from baseline | Measured by ad hoc developed questions ad hoc developed questions | Baseline and 12 months post intervention | |
Secondary | Change in knowledge and practices of foot care from baseline | Measured by hoc developed questions | Baseline and 12 months post intervention | |
Secondary | Change in tobacco smoking habit from baseline | Measured by hoc developed questions | Baseline and 12 months post intervention | |
Secondary | Change in alcohol consumption from baseline | Measured by hoc developed questions | Baseline and 12 months post intervention | |
Secondary | Change in unmet need of support of relevance for type 2 diabetes management from baseline | Measured by hoc developed questions | Baseline and 12 months post intervention | |
Secondary | Change in diabetes distress measured by Diabetes Distress - Screening Scale 17 (DDS-17) from baseline | The scale yields an overall distress score based on the average responses on the 1-6 scale for all 17 items. A mean question score of 3 or higher (moderate distress) indicate a level of distress worthy. Low score indicate low distress level.Lowest means score is 1 and highest possible mean score is 6. | Baseline and 12 months post intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04940962 -
Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion
|
N/A | |
Completed |
NCT05359341 -
Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?
|
N/A | |
Recruiting |
NCT04700813 -
Research Study for Rare Pathogenic Mutations Causing Type 2 Diabetes and Complications
|
||
Completed |
NCT05413330 -
Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.
|
Phase 2/Phase 3 | |
Recruiting |
NCT04927377 -
Accessible and Inclusive Diabetes Telecoaching Self-Management Program
|
N/A | |
Completed |
NCT05585268 -
Electronic Decision Support for Deprescribing in Patients on Hemodialysis
|
N/A | |
Active, not recruiting |
NCT05088616 -
Native American Diabetes Project
|
N/A | |
Not yet recruiting |
NCT03273738 -
Vascular and Metabolic Changes in Postmenopausal Diabetics
|
||
Active, not recruiting |
NCT04642911 -
Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy
|
||
Withdrawn |
NCT04283617 -
Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study
|
N/A | |
Recruiting |
NCT04769687 -
Symbiotics and Systemic Inflammation in Chronic Kidney Disease
|
Phase 2 | |
Withdrawn |
NCT06104358 -
Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT03341793 -
Impact of Changes in Muscle Secretome in the Remission of Type 2 Diabetes Mellitus Induced by Bariatric Surgery
|
N/A | |
Not yet recruiting |
NCT06080802 -
The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction
|
Phase 2/Phase 3 | |
Recruiting |
NCT04485845 -
Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression
|
Phase 4 | |
Recruiting |
NCT05050500 -
The Effect of Dapagliflozin on the Short-term Prognosis of Patients With Acute Myocardial Infarction
|
Phase 4 | |
Completed |
NCT04115657 -
The Effect of Different Starches of Boba Pearls and Sugar Substitutes Used in Milk Tea on Glycaemia, Insulinaemia and Appetite Control (Pearl Study)
|
N/A | |
Completed |
NCT06188572 -
The Effect of Peripheral Neuropathy Symptoms on Temporomandibular Joint Functionality
|
||
Completed |
NCT04120844 -
Effectiveness of Motivational Interviewing on Improving Care for Type 2 Diabetes Mellitus Patients in China
|
N/A | |
Completed |
NCT05789706 -
Use of a Smart-phone Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Non-insulin Dependent Diabetes Among Veterans
|
N/A |